Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 61 480 | déclaré | 19 mars 2026 | tx 58+468 875−149 889 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 18 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4 330 | 68.71 USD | |
| 17 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4 286 | 69.42 USD | |
| 19 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4 440 | 67.00 USD | |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 26 482 | — | |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4 790 | 0.00 USD | deriv |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8 148 | 0.00 USD | deriv |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8 020 | 0.00 USD | deriv |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5 524 | 0.00 USD | deriv |
| 05 mars 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 30 724 | 0.00 USD | deriv |
| 05 mars 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 19 306 | 0.00 USD | deriv |
| 09 juin 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 17 500 | 43.76 USD | |
| 20 mars 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 3 365 | 50.11 USD | |
| 18 mars 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 3 643 | 46.29 USD | |
| 19 mars 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 3 557 | 47.40 USD | |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 20 957 | — | |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8 019 | 0.00 USD | deriv |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8 148 | 0.00 USD | deriv |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4 790 | 0.00 USD | deriv |
| 05 mars 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 22 098 | 0.00 USD | deriv |
| 05 mars 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 33 691 | 0.00 USD | deriv |
| 18 mars 2024 | SALE | Tarsus Pharmaceuticals, Inc. | 4 766 | 30.60 USD | |
| 15 mars 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 12 938 | — | |
| 15 mars 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8 148 | 0.00 USD | deriv |
| 15 mars 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4 790 | 0.00 USD | deriv |
| 07 mars 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 32 079 | 0.00 USD | deriv |